ArticleProteomes2020

The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease.

Scott Bringans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.